Industry Trends

Andy Molnar, CEO of the Digital Therapeutics Alliance, provides insight into the digital therapeutic market and how Pear's bankruptcy has affected the industry.

Behavioral health isn’t the only part of health care seeing a drop in deals. PitchBook reports that health care investment has dropped for the fifth straight quarter in a row.

More and more providers are eyeing intensive outpatient programs (IOPs) to care for patients that need either a step down from an inpatient program or a step up from a traditional outpatient program.

While emerging DSOs may be backed by traditional lenders or private investors, the growth of larger DSOs is fueled specifically by private equity firms.

Enhabit is soon to be one of the only independent home health companies remaining on the public market.

Jobson Research and The Eyeconomist have compiled a new directory tracking close to 50 private equity-backed platforms.

The company uses both a proactive and reactive approach to JV opportunities. It has screened all market service areas in the country and evaluated if a de novo, M&A, or joint venture expansion makes sense for the business.

Many of last year’s deals were underscored by significant ties to artificial intelligence (AI) technologies, a trend likely to become more prevalent going forward.

A curation of noteworthy findings from Trilliant Health's research during the PHE that illustrate how healthcare evolved—and did not evolve—over the last three years.

The median deal size for late-stage rounds fell 25% to $6 million, the lowest figure recorded since Q2 2017.